i-med_pharma_logo
surgicallogo

STT Glaucoma Surgery

STT stands for sclerothalamotomy and is an ab interno-glaucoma operation in which you use bipolar RF diathermia. STT was first presented by Bojan Pajic and Gregoris Pallas in 1999. From a first study group (53 eyes) in 2002 there are now long-term results stretching over 72 months. From an average pre-operative value of 25.6 ± 2.3 mmHg the pressure sank to 14.8 ± 1.7 mmHg, the pressure-lowering eyedrops that were applied on average were reduced from 2.6 ± 1.0 to 0.21 ± 0.53.

These are results that, in contrast to methods like trabeculectomy or viscocanalostomy, are really very promising. In addition, STT is attractive for the following reasons:

  • High success rate
  • Effective, lasting lowering of pressure
  • Very low complication rate
  • Particularly easy and fast intervention
  • No application of anti-metabolites or needling

For more information on STT Glaucoma Surgery please contact us.